Literature DB >> 2761129

Mechanisms of action of eperisone on isolated dog saphenous arteries and veins.

S Inoue1, K Bian, T Okamura, H Okunishi, N Toda.   

Abstract

Effects of eperisone, an antispasmodic in skeletal muscle, were investigated in helical strips of dog saphenous artery and vein. Eperisone relaxed saphenous arteries and veins previously contracted with norepinephrine, serotonin, acetylcholine, K+, or Ba2+; but in contrast, it produced contractions in the blood vessels contracted with prostaglandin (PG) F2 alpha. Treatment with eperisone attenuated the contractions induced by norepinephrine and serotonin in the arteries and those by clonidine and phenylephrine in the veins. Eperisone inhibited angiotensin II-induced relaxations, mediated possibly by endogenous PGI2, but did not alter relaxations caused by exogenous PGI2. Treatment with eperisone (10(-5) M) potentiated the contractile response to electrical stimulation of adrenergic nerves; the potentiating effect was suppressed by yohimbine. The eperisone-induced contraction in PGF2 alpha-contracted arteries was inhibited by treatment with indomethacin or aspirin, although cyclooxygenase activity was not inhibited by eperisone. These results may indicate that eperisone blocks postjunctional alpha 1- and alpha 2-adrenergic, muscarinic, serotonergic receptors and prejunctional alpha 2 adrenoceptors and reduces PGI2 synthesis via a mechanism other than cyclooxygenase inhibition.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2761129     DOI: 10.1254/jjp.50.271

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  3 in total

1.  Oral muscle relaxant may induce immediate allergic reactions.

Authors:  Gyu-Young Hur; Eui Kyung Hwang; Jae-Young Moon; Young-Min Ye; Jae-Jeong Shim; Hae-Sim Park; Kyung-Ho Kang
Journal:  Yonsei Med J       Date:  2012-07-01       Impact factor: 2.759

Review 2.  Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects.

Authors:  Stefan Quasthoff; Claudia Möckel; Walter Zieglgänsberger; Wolfgang Schreibmayer
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

3.  Eperisone hydrochloride-induced maculopapular rash.

Authors:  Namrata Balaraddiyavar; Aruna Bhushan; Basavaraj C Kotinatot; Gouramma Huggi
Journal:  Indian J Pharmacol       Date:  2016 Sep-Oct       Impact factor: 1.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.